SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-023846
Filing Date
2023-03-29
Accepted
2023-03-29 07:45:13
Documents
14
Period of Report
2023-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea175977-8k_biomx.htm   iXBRL 8-K 35343
2 PRESS RELEASE DATED MARCH 29, 2023 ea175977ex99-1_biomx.htm EX-99.1 64265
  Complete submission text file 0001213900-23-023846.txt   340692

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE phge-20230329.xsd EX-101.SCH 4472
4 XBRL DEFINITION FILE phge-20230329_def.xml EX-101.DEF 27449
5 XBRL LABEL FILE phge-20230329_lab.xml EX-101.LAB 38219
6 XBRL PRESENTATION FILE phge-20230329_pre.xml EX-101.PRE 26069
8 EXTRACTED XBRL INSTANCE DOCUMENT ea175977-8k_biomx_htm.xml XML 7447
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 23771782
SIC: 2836 Biological Products, (No Diagnostic Substances)